{
 "drug": "Haloperidol Decanoate Injection",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "01/09/2026",
 "dayN": 228,
 "cat": "Psychiatry",
 "companies": [
  "Fresenius Kabi USA, LLC"
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "01/09/2026",
   "update_type": "New",
   "initial_posting_date": "01/09/2026",
   "package_ndc": "63323-469-01",
   "generic_name": "Haloperidol Decanoate Injection",
   "contact_info": "888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA074893"
    ],
    "brand_name": [
     "HALOPERIDOL DECANOATE"
    ],
    "generic_name": [
     "HALOPERIDOL DECANOATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-469",
     "63323-471"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR"
    ],
    "substance_name": [
     "HALOPERIDOL DECANOATE"
    ],
    "rxcui": [
     "859867",
     "859871",
     "1719803",
     "1719862"
    ],
    "spl_id": [
     "86dff2aa-2ab3-42fc-989e-619b13ace573"
    ],
    "spl_set_id": [
     "ca9896e0-fb2e-46a4-8700-20d144c14764"
    ],
    "package_ndc": [
     "63323-469-01",
     "63323-469-05",
     "63323-471-01",
     "63323-471-05"
    ],
    "unii": [
     "AC20PJ4101"
    ]
   },
   "update_date": "01/09/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Injection",
   "presentation": "Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-01)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "01/09/2026",
   "update_type": "New",
   "initial_posting_date": "01/09/2026",
   "package_ndc": "63323-469-05",
   "generic_name": "Haloperidol Decanoate Injection",
   "contact_info": "888-386-1300",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "ANDA074893"
    ],
    "brand_name": [
     "HALOPERIDOL DECANOATE"
    ],
    "generic_name": [
     "HALOPERIDOL DECANOATE"
    ],
    "manufacturer_name": [
     "Fresenius Kabi USA, LLC"
    ],
    "product_ndc": [
     "63323-469",
     "63323-471"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "INTRAMUSCULAR"
    ],
    "substance_name": [
     "HALOPERIDOL DECANOATE"
    ],
    "rxcui": [
     "859867",
     "859871",
     "1719803",
     "1719862"
    ],
    "spl_id": [
     "86dff2aa-2ab3-42fc-989e-619b13ace573"
    ],
    "spl_set_id": [
     "ca9896e0-fb2e-46a4-8700-20d144c14764"
    ],
    "package_ndc": [
     "63323-469-01",
     "63323-469-05",
     "63323-471-01",
     "63323-471-05"
    ],
    "unii": [
     "AC20PJ4101"
    ]
   },
   "update_date": "01/09/2026",
   "therapeutic_category": [
    "Psychiatry"
   ],
   "dosage_form": "Injection",
   "presentation": "Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-05)",
   "company_name": "Fresenius Kabi USA, LLC",
   "status": "To Be Discontinued"
  }
 ]
}